State Street’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.66M Buy
664,768
+434,730
+189% +$1.74M ﹤0.01% 3209
2025
Q1
$732K Buy
230,038
+24,500
+12% +$77.9K ﹤0.01% 3503
2024
Q4
$1.1M Buy
205,538
+27,292
+15% +$146K ﹤0.01% 3473
2024
Q3
$941K Buy
178,246
+57,943
+48% +$306K ﹤0.01% 3497
2024
Q2
$219K Hold
120,303
﹤0.01% 3793
2024
Q1
$214K Sell
120,303
-18,100
-13% -$32.2K ﹤0.01% 3860
2023
Q4
$244K Hold
138,403
﹤0.01% 3849
2023
Q3
$202K Hold
138,403
﹤0.01% 3939
2023
Q2
$317K Buy
138,403
+25,800
+23% +$59.1K ﹤0.01% 3850
2023
Q1
$102K Hold
112,603
﹤0.01% 4318
2022
Q4
$95.7K Hold
112,603
﹤0.01% 4382
2022
Q3
$92K Hold
112,603
﹤0.01% 4490
2022
Q2
$111K Hold
112,603
﹤0.01% 4481
2022
Q1
$185K Buy
112,603
+12,203
+12% +$20K ﹤0.01% 4408
2021
Q4
$242K Buy
100,400
+34,000
+51% +$82K ﹤0.01% 4266
2021
Q3
$321K Buy
66,400
+36,800
+124% +$178K ﹤0.01% 4158
2021
Q2
$79K Buy
+29,600
New +$79K ﹤0.01% 4399
2019
Q4
Sell
-21,299
Closed -$64K 3812
2019
Q3
$64K Buy
21,299
+789
+4% +$2.37K ﹤0.01% 3704
2019
Q2
$77K Sell
20,510
-191,807
-90% -$720K ﹤0.01% 3689
2019
Q1
$854K Buy
212,317
+8,541
+4% +$34.4K ﹤0.01% 3361
2018
Q4
$748K Buy
203,776
+20,552
+11% +$75.4K ﹤0.01% 3382
2018
Q3
$1.57M Buy
183,224
+16,586
+10% +$142K ﹤0.01% 3328
2018
Q2
$1.83M Buy
166,638
+70,159
+73% +$770K ﹤0.01% 3307
2018
Q1
$1.11M Sell
96,479
-538
-0.6% -$6.19K ﹤0.01% 3326
2017
Q4
$1M Buy
97,017
+27,664
+40% +$286K ﹤0.01% 3353
2017
Q3
$1.1M Buy
69,353
+6,878
+11% +$109K ﹤0.01% 3360
2017
Q2
$756K Buy
62,475
+9,779
+19% +$118K ﹤0.01% 3373
2017
Q1
$1.09M Buy
52,696
+1,437
+3% +$29.8K ﹤0.01% 3239
2016
Q4
$732K Sell
51,259
-2,849
-5% -$40.7K ﹤0.01% 3336
2016
Q3
$890K Buy
54,108
+25,513
+89% +$420K ﹤0.01% 3214
2016
Q2
$407K Buy
+28,595
New +$407K ﹤0.01% 3418